WRF Yeast Licensing Program for
Expression of Polypeptides in Yeast
Tech ID: 10-82-13
Non-Confidential Summary
Claims for US Patent No. 5,618,676 Claims for US Patent No. 5,854,018 Claims for US Patent No. 5,856,123 Claims for US Patent No. 5,919,651 News Release Ronald A. Hitzeman, Ph.D., (650) 871-6484, an inventor on the
patents, provides consulting services regarding recombinant yeast
expression. ApoLife, with its
novel 'Twin Cassette' technologies, offers high
quality recombinant protein and antibody expression in yeast, while
maintaining both time and cost effectiveness. These technologies
include yeast promoters and high copy plasmids, media formulations,
fermentation conditions, and proprietary yeast strains to obtain optimal
secretion and maximum yield. A strong technical team with over 20 years
of
experience in recombinant protein expression systems, ApoLife offers
both contract services and consultations under a license from WRF. Research Use Only License Agreement
Please print, complete and return two copies of the
AGREEMENT to Washington Research Foundation. The EFFECTIVE
DATE will be the date of signing by a WRF director. A copy
of the signed AGREEMENT will be returned to LICENSEE promptly.
An invoice for the License Fee will be faxed within 1 business day of the
EFFECTIVE DATE. The AGREEMENT will not be valid unless executed
by both parties and payment in the amount invoiced is received
within 15 days of the EFFECTIVE DATE.
For additional information, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
2815 Eastlake Avenue E, Suite 300
Seattle, WA 98102
Tel: (206) 336.5600
Fax: (206) 336.5615
betschei@wrfseattle.org
|
